tiprankstipranks
GlycoMimetics (GLYC)
NASDAQ:GLYC

GlycoMimetics (GLYC) Stock Investors

806 Followers
Based on 729,459 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold GLYC
On average, investors allocate 4.47% of their portfolios to GLYC
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 729,459 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding GLYC

0.2%
Last 7
Days
13.6%
Last 30
Days
Percentages indicate the change in the number of portfolios holding GLYC, out of 729,459 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

GLYC Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
10.64%
$3.18
Reduced
0.80%
$0.64
Reduced
5.32%
$3.03
Based on the activity of 13,706 investors who made their portfolios public
The table shows changes in GLYC in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

GLYC Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Assertio Therapeutics
2.65%
-1.17%
-9.09%
82.20M
Healthcare
Coherus Biosciences
2.65%
-1.13%
-8.66%
247.43M
Healthcare
ChargePoint Holdings
3.90%
-0.95%
-7.43%
575.77M
Consumer Cyclical
AMC Entertainment
5.45%
-0.75%
-6.75%
901.53M
Communication Services
Plug Power
4.91%
-0.98%
-6.71%
1.70B
Industrials
Merck & Company
4.14%
-0.23%
-1.16%
321.49B
Healthcare
GE Aerospace
5.49%
+1.75%
+7.24%
164.20B
Industrials
Micron
5.68%
+0.43%
+12.72%
120.84B
Technology
Enterprise Products Partners
5.83%
-0.15%
-2.31%
62.88B
Energy
Riot Platforms
4.95%
+1.15%
+0.14%
2.85B
Financial
Based on the activity of 729,459 active portfolios
Open your Smart Portfolio

GLYC Investor Analysis

GLYC investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
9.6%
of GLYC holders
are under 35
Average Segment Performance
Average P/E Ratio55.48
Beta6.58
Dividend Yield6.31%
GLYC investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
47.8%
of GLYC holders
are between 35–55
Average Segment Performance
Average P/E Ratio59.75
Beta11.38
Dividend Yield17.85%
GLYC investors over 55

Over 55

5.0%
Last 30 days
Holdings Change
42.7%
of GLYC holders
are over 55
Average Segment Performance
Average P/E Ratio50.99
Beta4.10
Dividend Yield29.58%
Overview of age group and performance of GLYC stock investors
See who invests in GLYC according to age group and performance.

FAQ

How many retail Investors hold GLYC?
<0.1% of TipRanks' retail investors hold GLYC in their portfolios.
    What is GLYC Investor Sentiment?
    GLYC’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of GLYC in the last 7 days?
      ▲ 0.2% of TipRanks' retail investors changed their holding of GLYC in the last 7 days.
        What percentage of retail investors changed their holding of GLYC in the last 30 days?
        ▲ 13.6% of TipRanks' retail investors changed their holding of GLYC in the last 30 days.
          What is the average age of retail investors who hold GLYC?
          The average age of GLYC Holders is between 35–55.
            What other stocks have GLYC investors also bought?
            GLYC Investors also bought ASRT, CHRS, CHPT, AMC, PLUG, MRK, GE, MU, EPD, RIOT.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              AAgilent
              CORCencora
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis